News | October 27, 2010

Varian Medical Systems, Vision RT Reach Distribution Agreement

October 27, 2010 – A new distribution agreement has been signed allowing Varian Medical Systems to offer Vision RT’s motion management products to its customers. The two companies have been working in collaboration to facilitate the interoperability between their respective products.

Vision RT’s patient tracking and monitoring product, AlignRT, is now fully compatible with Varian’s Motion Management Interface for the Varian Clinac iX and Trilogy linear accelerators. AlignRT provides automated couch control and radiation beam hold if patient motion that exceeds a user defined tolerance is detected. In addition, GateCT facilitates 4-D CT reconstruction, and together with the GateRT capabilities for markerless respiratory gating provides a comprehensive end-to-end solution for respiratory-gated radiation therapy.

“We are excited about the integration of Varian’s radiation delivery and Vision RT’s advanced motion management solutions”, says Arno J. Mundt, M.D., professor and chair of the department of radiation oncology at University of California, San Diego. “This allows us to entertain a new treatment paradigm that combines precise treatment delivery, patient comfort and safety.”

“We believe that Vision RT has developed a very robust, multi-purpose optical guidance solution," says Corey Zankowski, senior director, product management of Varian. “Vision RT will help to maintain the high level of precision provided by Varian’s imaged-guided treatment technology throughout the entire treatment session. With increased certainty in the target position during the course of treatment, clinicians will be able to spare more normal tissue, potentially improving patient outcomes”

For more information: www.visionrt.com

Related Content

Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...